AEMPS recalls the product Juliet Capsule Lepidum L-Carnitine Capsules
Publication date: October 7, 2024
Category: drugs for humans, illegal drugs
Reference: ICM (MI), 06/2024
- AEMPS reports the presence in this product of sibutramine, an anorexigenic active ingredient that causes an increase in heart rate and blood pressure, which can cause arrhythmias, coronary artery disease and serious vascular disorders.
- This substance is not declared on the label, hiding its true composition from the consumer.
- The agency has ordered a marketing ban and the withdrawal of all copies of this product from the market and recommends against consumption.
The Spanish Agency for Medicines and Health Products (AEMPS), through the Ceuta Civil Guard Command and the Ceuta Customs Service, has become aware of the marketing of the product Juliette L-Carnitine Lepidum capsules.
According to the analysis carried out by the official control laboratory of AEMPS, the above-mentioned product contains the active substance sibutramine in sufficient quantity to restore, correct or modify physiological function by exerting a pharmacological action, which gives it the legal status of a medicinal product. . This substance is not declared on its labeling, which deceptively lists a number of herbal ingredients, giving false information about its safety, which can cause serious harm to the health of people who consume it.
Sibutramine is an anorectic (appetite suppressant) active ingredient that promotes a feeling of fullness and also increases calorie expenditure. In addition, sibutramine causes an increase in heart rate and blood pressure, which can cause arrhythmias, coronary artery disease and serious vascular disorders in some patients. Other side effects that may occur while consuming it are dry mouth, headache, insomnia, constipation, etc. Moreover, it has a large number of interactions with other medications.
Sibutramine was included in prescription drugs for the treatment of obesity, the marketing of which was suspended in the European Union due to the fact that its consumption was associated with serious cardiovascular side effects, as reflected in the AEMPS Information Note on Sibutramine (Reductil® ). » published January 21, 2010
Given the above-mentioned risks, as well as the fact that the product was not assessed and approved before being placed on the market, AEMPS has taken precautionary measures by banning its marketing and requiring the withdrawal of all samples from the market, and recommending that it not be consumed as food.
Product Image Capsules Juliette L-Carnitine Lepidum capsules